top of page

News

PICK UP

PRESS RELEASE | DECEMBER 18, 2025

CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing

Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media.

New

Event | September 17, 2026

CHITOSE to Partner, Present, and Exhibit High-Yield Cell Line Development Technologies at BioJapan 2026 (Booth #B-19)

Event | September 1, 2026

CHITOSE to Present High-Yield Intensified CHO-MK Cell Culture at BPI Boston 2026

PRESS RELEASE | DEC 17, 2025

High-Performance Novel HAT Cell Line for Gene Therapy

Scientific Publications

Establishment of a novel cell line, CHO-MK, derived from Chinese hamster ovary tissues for biologics manufacturing

Kenji Masuda, Michi Kubota et al.

Journal of Bioscience and Bioengineering (2024), Volume 137 (6), 471-479

Enhancing monoclonal antibody production efficiency using CHO-MK cells and specific media in a conventional fed-batch culture

Hisashi Saeki, et al.

Cytotechnology (2025), Volume 77 (1)

From failures to insights: The role of surge tanks in integrated and continuous bioprocessing for antibody production

Masumi Nasukawa-Morimoto, et al.

Processes (2025), Volume 13 (10), 3336

Enhanced antibody production in Chinese hamster ovary cell cultures supplemented with barley shochu distillation by-product supernatant

Akihiro Nakamura, et al.

Journal of Bioscience and Bioengineering (2025), Volume 140 (5), 341-349

Hybrid modeling of CHO cell cultivation in monoclonal antibody production with an impurity generation module

Kozue Okamura, et al.

Industrial & Engineering Chemistry Research (2022), Volume 61 (40)

An S100A8/A9 neutralizing antibody potently ameliorates contact hypersensitivity and atopic dermatitis symptoms

Yuma Gohara, et al.

Journal of Investigative Dermatology (2025), Volume 145 (8), 1930-1945

Frequently asked questions

bottom of page